|
|
???tair.name??? >
???browser.page.title.author???
|
"huang dc"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2020-04 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono, J;Lin, CC;Chen, LT;Corral, J;Michalarea, V;Rihawi, K;Ong, M;Lee, JH;Hsu, CH;Yang, JC;Shiah, HS;Yen, CJ;Anthoney, A;Jove, M;Buschke, S;Fuertig, R;Schmid, U;Goeldner, RG;Strelkowa, N;Huang, DC;Bogenrieder, T;Twelves, C;Cheng, AL |
| 國家衛生研究院 |
2014-05 |
A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers
|
Lin, CC;Chang, KY;Huang, DC;Marriott, V;Beijsterveldt, L;Chen, LT;Chang, AL |
| 國家衛生研究院 |
2012-09 |
Early data from a phase I study of nintedanib (BIBF1120) in Asian patients with advanced hepatocellular carcinoma
|
Yen, C;Shen, Y;Shiah, H;Chen, J;Hsu, C;Huang, DC;Hocke, J;Su, W;Cheng, A |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
